-
1كتاب
المؤلفون: Kırmızıbayrak, Petek Ballar, Gözen, Oğuz, Erzurumlu, Yalçın, Barrio, R, Sutherland, JD, Rodriguez, MS
المساهمون: Bursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Moleküler Biyoloji ve Genetik Bölümü., Tepedelen, Burcu Erbaykent, CNH-6913-2022, 47860936500
مصطلحات موضوعية: Biochemistry & molecular biology, Pathology, Research & experimental medicine, Prostate cancer, Ubiquitin, Ubiquitin-like, Deubiquitinase, Autophagy, Unfolded protein response, Androgen receptor-activty, Tumor-suppressor gene, Deubiquitinating enzyme USP12, Ubiquitin ligase SIAH2, Heat-shock proteins, Wild-type spop, Cell-proliferation, Homeobox gene, Transcriptional activity, Deubiquitinating enzymes, Endoplasmic reticulum-associated degradation, Humans, Male, Prostatic neoplasms, Proteasome endopeptidase complex, Proteostasis, Medicine, research & experimental, Ubiquitin-Specific Proteases, Androgen, Androgen receptor
العلاقة: SBAG-108S056/114S062; Makale - Uluslararası Hakemli Dergi; Advances in Experimental Medicine and Biology; Yurt içi; Kırmızıbayrak, P. B. vd. (2020). "Divergent modulation of proteostasis in prostate cancer". ed. R. Barrio vd. Advances in Experimental Medicine and Biology, 1233, 117-151.; https://doi.org/10.1007/978-3-030-38266-7_5Test; https://link.springer.com/chapter/10.1007/978-3-030-38266-7_5Test; http://hdl.handle.net/11452/30992Test; 000530838600006; 2-s2.0-85083257850; 117; 151; 1233
-
2دورية أكاديمية
المؤلفون: Yerlikaya, Azmi, Okur, Emrah, Baykal, Ahmet Tarik, Acilan, Ceyda, Boyaci, Ihsan
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı., orcid:0000-0003-4875-5472, Ulukaya, Engin, K-5792-2018, 6602927353
مصطلحات موضوعية: Biochemistry & Molecular biology, Apoptosis, Bortezomib, Cancer, Proteasome, Proteomics, Ubiquitin, Ubiquitin-proteasome pathway, In-vitro, Inhibitor bortezomib, Protein-degradation, Kappa-B, Sensitivity, Death, Decarboxylase, P53, Antineoplastic agents, Boronic acids, Breast neoplasms, Cell line, tumor, DNA replication, DNA, neoplasm, Energy metabolism, Female, Humans, Proteasome endopeptidase complex, Protein folding, Protein processing
وصف الملف: application/pdf
العلاقة: SBAG 109S035; Makale - Uluslararası Hakemli Dergi; Journal of Proteomics; Yurt içi; Yerlikaya, A. vd. (2015). "A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line". Journal of Proteomics, 113, 315-325.; https://doi.org/10.1016/j.jprot.2014.09.010Test; https://www.sciencedirect.com/science/article/pii/S1874391914004266Test; http://hdl.handle.net/11452/34162Test; 000347582200022; 2-s2.0-84938493066; 315; 325; 113
الإتاحة: https://doi.org/10.1016/j.jprot.2014.09.010Test
http://hdl.handle.net/11452/34162Test
https://www.sciencedirect.com/science/article/pii/S1874391914004266Test -
3دورية أكاديمية
المؤلفون: Yerlikaya, Azmi, Okur, Emrah, Baykal, Ahmet Tarik, Acilan, Ceyda, Boyaci, Ihsan
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı., orcid:0000-0003-4875-5472, Ulukaya, Engin, K-5792-2018, 6602927353
مصطلحات موضوعية: Biochemistry & Molecular biology, Apoptosis, Bortezomib, Cancer, Proteasome, Proteomics, Ubiquitin, Ubiquitin-proteasome pathway, In-vitro, Inhibitor bortezomib, Protein-degradation, Kappa-B, Sensitivity, Death, Decarboxylase, P53, Antineoplastic agents, Boronic acids, Breast neoplasms, Cell line, tumor, DNA replication, DNA, neoplasm, Energy metabolism, Female, Humans, Proteasome endopeptidase complex, Protein folding, Protein processing
وصف الملف: application/pdf
العلاقة: SBAG 109S035; Makale - Uluslararası Hakemli Dergi; Journal of Proteomics; Yurt içi; Yerlikaya, A. vd. (2015). "A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line". Journal of Proteomics, 113, 315-325.; https://doi.org/10.1016/j.jprot.2014.09.010Test; https://www.sciencedirect.com/science/article/pii/S1874391914004266Test; http://hdl.handle.net/11452/34162Test; 000347582200022; 2-s2.0-84938493066; 315; 325; 113
الإتاحة: https://doi.org/10.1016/j.jprot.2014.09.010Test
http://hdl.handle.net/11452/34162Test
https://www.sciencedirect.com/science/article/pii/S1874391914004266Test -
4مراجعة
المؤلفون: Yerlikaya, Azmi
المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/İmmünoloji Anabilim Dalı., orcid:0000-0001-8399-8942, Kanbur, Ertan, AAW-6971-2021, 57218292727
مصطلحات موضوعية: Pharmacology & pharmacy, Breast-cancer, Bortezomib resistance, Multiple-myeloma, 20s proteasome, Misfolded proteins, C-terminus, Degradation, Melanoma, Ixazomib, Enzymes, Bortezomib, Cancer, Myeloma, Proteasome, Resistance, Ubiquitin, Animals, Clinical trials as topic, Drug resistance, neoplasm, Humans, Neoplasms, Proteasome endopeptidase complex, Proteasome inhibitors, Carfilzomib, Delanzomib, Oprozomib, Salinosporamide A, Proteasome inhibitör
العلاقة: Makale - Uluslararası Hakemli Dergi; Current Drug Targets; Yurt içi; Yerlikaya, A. ve Kanbur, E. (2020). "The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells". Current Drug Targets, 21(13), 1313-1325.; https://doi.org/10.2174/1389450121666200525004714Test; https://pubmed.ncbi.nlm.nih.gov/32448101Test/; http://hdl.handle.net/11452/34729Test; 000581913300004; 2-s2.0-85091720797; 1313; 1325; 21; 13
الإتاحة: https://doi.org/10.2174/1389450121666200525004714Test
http://hdl.handle.net/11452/34729Test
https://pubmed.ncbi.nlm.nih.gov/32448101Test/ -
5مراجعة
المؤلفون: Yerlikaya, Azmi
المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/İmmünoloji Anabilim Dalı., orcid:0000-0001-8399-8942, Kanbur, Ertan, AAW-6971-2021, 57218292727
مصطلحات موضوعية: Pharmacology & pharmacy, Breast-cancer, Bortezomib resistance, Multiple-myeloma, 20s proteasome, Misfolded proteins, C-terminus, Degradation, Melanoma, Ixazomib, Enzymes, Bortezomib, Cancer, Myeloma, Proteasome, Resistance, Ubiquitin, Animals, Clinical trials as topic, Drug resistance, neoplasm, Humans, Neoplasms, Proteasome endopeptidase complex, Proteasome inhibitors, Carfilzomib, Delanzomib, Oprozomib, Salinosporamide A, Proteasome inhibitör
العلاقة: Makale - Uluslararası Hakemli Dergi; Current Drug Targets; Yurt içi; Yerlikaya, A. ve Kanbur, E. (2020). "The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells". Current Drug Targets, 21(13), 1313-1325.; https://doi.org/10.2174/1389450121666200525004714Test; https://pubmed.ncbi.nlm.nih.gov/32448101Test/; http://hdl.handle.net/11452/34729Test; 000581913300004; 2-s2.0-85091720797; 1313; 1325; 21; 13
الإتاحة: https://doi.org/10.2174/1389450121666200525004714Test
http://hdl.handle.net/11452/34729Test
https://pubmed.ncbi.nlm.nih.gov/32448101Test/